Clinical trials

  • metformin hydrochloride for Myelodysplastic syndromes (MDS) - very low and low risk|Clonal cytopenia of undetermined significance (CCUS)
  • DAPAGLIFLOZIN for Acute kidney injury (AKI) | Reduced estimated glomerular filtration rate (reduced eGFR) | Elevated NT-proBNP (cardiac biomarker)
  • Colchicine (also listed with opium standardized powdered and tiemonium methylsulphate in product record) for Chronic kidney disease (moderate) | Cardiovascular disease (secondary prevention)
  • LURBINECTEDIN for Small cell lung cancer
  • HUMAN PLASMA GELSOLIN, RECOMBINANT for Acute respiratory distress syndrome (ARDS)
  • LITIFILIMAB for Systemic lupus erythematosus
  • ABBV-969 for Prostate cancer | Metastatic castration-resistant prostate cancer
  • VONICOG ALFA for Severe von Willebrand disease
  • TALQUETAMAB for Multiple myeloma
  • AUTOLOGOUS BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELLS, HAEMATOPOIETIC STEM/PROGENITOR CELLS, ACTIVATED DENDRITIC CELLS AND T HELPER CELLS for Peripheral arterial disease | Critical limb ischemia
  • ANV600 for Advanced solid tumors
  • ELVN-001 for Chronic myeloid leukemia